Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × gemcitabine-oxaliplatin regimen × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Biliary Tract Neoplasms 1

Interventions

Specimen Handling 357 Magnetic Resonance Spectroscopy 295 pembrolizumab 289 Biopsy 225 Carboplatin 206 Cyclophosphamide 184 Cisplatin 167 Paclitaxel 156 Nivolumab 137 Gemcitabine 130 venetoclax 116 Radiotherapy 112 Bevacizumab 109 Dexamethasone 101 fludarabine 92 Rituximab 87 Pemetrexed 87 Fluorouracil 86 Oxaliplatin 85 Doxorubicin 84 durvalumab 81 Docetaxel 79 atezolizumab 76 Prednisone 76 Radiation 73 Lenalidomide 72 Ipilimumab 66 X-Rays 65 Leucovorin 64 Capecitabine 64

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05771480 2026-02-23

TOURMALINE

AstraZeneca

Phase 3 Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡